Skip to content
Stop using now Drug recall · FDA · Published August 20, 2015

Hospira Recalls Ketamine Vials Due to Cracked Glass

Hospira Inc. recalls Ketamine Hydrochloride Injection vials due to cracked and leaking glass containers. Check lot numbers for affected units.

🇺🇸 FDA recall #D-0418-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling Ketamine Hydrochloride Injection, USP (100 mg/mL) packaged in 5 mL multi-dose glass fliptop vials because some containers are defective. Customer complaints identified cracked and leaking glass vials within the distributed boxes. The recall affects a total of 83,320 vials distributed nationwide. Read more at govinfonow.com/recall/43823-hospira-inc-recalls-ketamine-hydrochloride-injection-usp-100-mg-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/43823-hospira-inc-recalls-ketamine-hydrochloride-injection-usp-100-mg-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-0418-2015

Cite this page

“Hospira Recalls Ketamine Vials Due to Cracked Glass.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43823-hospira-inc-recalls-ketamine-hydrochloride-injection-usp-100-mg-ml. Based on FDA recall #D-0418-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0418-2015%22&limit=1).

The FDA announced on 2015-08-20 that Hospira Inc. voluntarily recalled Ketamine Hydrochloride Injection, USP (100 mg/mL) due to defective containers. The agency cited customer complaints of cracked and leaking glass vials for the Class II recall.

How to tell if you have it

  • Brand: Hospira
  • Product: Ketamine Hydrochloride Injection, USP (100 mg/mL)
  • Packaging: 5 mL multi-dose glass fliptop vials, 10 vials per box
  • NDC: 00409-2051-05
  • Lot codes: 43406DD (Exp 7/1/2016), 44255DD (Exp 8/1/2016)
  • Distribution: Nationwide

The hazard

The recall addresses defective containers, specifically cracked and leaking glass vials. The FDA noted that these defects were identified through customer complaints.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include Fresenius Kabi Ketamine HCl Injection Recall (2026-02-05), Hikma Ramipril Capsules 10mg Recall (2026-08-24), and Wells Pharma Ketamine Injectable Solution Recall (2026-04-01).

How to tell if you have this one

Check if you have Ketamine Hydrochloride Injection, USP (100 mg/mL) in 5 mL multi-dose glass fliptop vials manufactured by Hospira Inc. Look for NDC 00409-2051-05 and Lot numbers 43406DD (Exp 7/1/2016) or 44255DD (Exp 8/1/2016).

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the affected vials

    Do not use any Ketamine Hydrochloride Injection vials matching the recalled lot numbers due to the risk of cracked and leaking containers.

  2. Contact your supplier or provider

    Reach out to the pharmacy or healthcare provider where the medication was obtained for further instructions on replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Aug 20, 201512. FDA classified it Class II: Sep 15, 201523. Published in FDA’s Enforcement Report: Sep 23, 201534. FDA terminated the recall: Apr 3, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0418-2015 (August 20, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0418-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA